(Q45176452)

10 December 2017

title

CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B. (English)

1 reference

systemic lupus erythematosus

10 December 2017

main subject

1 reference

10

Stephan Stilgenbauer

0 references

Karin Scharffetter-Kochanek

12

object named as

Karin Scharffetter-Kochanek

1 reference

10 December 2017

Magdalena Hagn

1

1 reference

10 December 2017

Verena Ebel

2

1 reference

10 December 2017

Kai Sontheimer

3

1 reference

10 December 2017

Elisabeth Schwesinger

4

1 reference

10 December 2017

Oleg Lunov

5

1 reference

10 December 2017

Thamara Beyer

6

1 reference

10 December 2017

Dorit Fabricius

7

1 reference

10 December 2017

Thomas F E Barth

8

1 reference

10 December 2017

Andreas Viardot

9

1 reference

10 December 2017

Julia Hepp

11

1 reference

10 December 2017

Thomas Simmet

13

1 reference

10 December 2017

Bernd Jahrsdörfer

14

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

European Journal of Immunology

10 December 2017

published in

1 reference

10 December 2017

volume

40

1 reference

10 December 2017

issue

7

1 reference

10 December 2017

page(s)

2060-2069

1 reference

Origins and functions of B-1 cells with notes on the role of CD5

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Role of B-1a cells in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Dysfunctional B cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

The paradox of CD5-expressing B cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

The role of IL-21 in regulating B-cell function in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Interleukin 21 as a target of intervention in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Human and mouse granzyme A induce a proinflammatory cytokine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Granzyme B cleavage of autoantigens in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Granzyme B: evidence for a role in the origin of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Extracellular granzymes: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Non-apoptotic functions of granzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Interleukin-21 mRNA expression during virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Granzyme B is dispensable for immunologic tolerance to self in a murine model of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Identification and characterization of circulating human transitional B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Granzyme B leakage-induced cell death: a new type of activation-induced natural killer cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Analysis of protein processing by N-terminal proteomics reveals novel species-specific substrate determinants of granzyme B orthologs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

IL-21 is required to control chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Immunology. A chronic need for IL-21

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

A vital role for interleukin-21 in the control of a chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

7 January 2021

Development of psoriasis after B cell depletion with rituximab

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

7 January 2021

Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

7 January 2021

Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

7 January 2021

Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

7 January 2021

IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200940113

7 January 2021

Identifiers

DOI

10.1002/EJI.200940113

1 reference

release_eyalxoxxwbdv5epdh4r6lbvrra

10 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eyalxoxxwbdv5epdh4r6lbvrra

24 November 2022

mapped directly with Wikidata item

1 reference